OVIOS Announces Limited-Time 40% New Year Promotion on Its Flagship U-Shaped Sectional Sofa GlobeNewswire December 29, 2025 Los Angeles, California, Dec. 28, 2025 (GLOBE NEWSWIRE) — As the New Year approaches, OVIOS, the global home brand celebrated for merging modern design with everyday comfort, invites families to begin 2026 surrounded by warmth and ease. OVIOS […]
NEW YORK, NY / ACCESS Newswire / December 28, 2025 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Synopsys, Inc. (NASDAQ:SNPS) securities. If you suffered a loss on your Synopsys, Inc. investment and would like to explore a potential
Last month, LiuGong (000528.SZ) officially unveiled its new E-Intelligence brand at the 2025 Global Dealer Conference and 11•26 Global Customer Day held in Liuzhou. The global launch marks a major milestone in LiuGong's green transformation and its next phase of sustainable development. Centered on the brand manifesto “FORWARD GREEN, POWER THE EXTREMES,” the launch underscores
Medical Channel Asia's ongoing eczema survey reveals how chronic itch drives withdrawal, emotional strain, and missed celebrations during a period traditionally associated with connection and joy. For many, the festive season is marked by reunions, shared meals and long-awaited gatherings. For Mr Li, however, it often comes with apprehension. Festive periods tend to disrupt the
CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announced that it has submitted two separate Investigational New Drug (IND) applications to the National Medical Products Administration (NMPA) for its allogeneic BCMA-targeted CAR-T cell therapy product, CT0596. The applications seek to initiate two corresponding Phase Ib/â…i clinical trials
NEW YORK, NY / ACCESS Newswire / December 28, 2025 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Stride, Inc. (NYSE:LRN) securities. If you suffered a loss on your Stride investment and would like to explore a potential recovery
(HKSE:6628),(TAI:6589),(TAI:6589.TW), PRINCETON, N.J. and HANGZHOU, China, Dec. 28, 2025 (GLOBE NEWSWIRE) — Transcenta Holding Limited (HKEX: 06628) (“Transcenta Therapeutics”), a global clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, today announced it has entered into a strategic collaboration and non-exclusive licensing agreement with EirGenix Inc. (“EirGenix”) (TWSE:
Transcenta Therapeutics Announces Strategic Collaboration and Non-exclusive Licensing Agreement to Advance Integrated Continuous Biomanufacturing and Expand Global Access to Affordable Biologics GlobeNewswire December 29, 2025 PRINCETON, N.J. and HANGZHOU, China, Dec. 28, 2025 (GLOBE NEWSWIRE) — Transcenta Holding Limited (HKEX: 06628) (“Transcenta Therapeutics”), a global clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research,
NEW YORK CITY, NY AND NEW ORLEANS, LA / ACCESS Newswire / December 28, 2025 / Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have December 30, 2025 to file lead plaintiff applications in securities class action lawsuits against Synopsys,
NEW YORK, NY / ACCESS Newswire / December 28, 2025 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Perrigo Company plc (NYSE:PRGO) securities. If you suffered a loss on your Perrigo Company plc investment and would like to explore